Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/MRMD stock hub

CSE/MRMD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/MRMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

46.4M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/MRMD

In the news

Latest news · CSE/MRMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-20.3

P25 -121.5P50 -40.9P75 0.5

ROIC-1.6

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/MRMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CA
Employees	866
Employees Change	91%
Employees Change Percent	10.94
Enterprise value	CAD 168.7M
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	US56782V1070
Last refreshed	2026-05-10
Market cap	CAD 46.4M
Price	CAD 0.12
Price currency	CAD
Rev Per Employee	253,049.22x
Sector	Healthcare
Sic	2834
Symbol	cse/MRMD
Website	https://www.marimedinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-42.78%
EV Earnings	-8.5x
EV/EBITDA	10.9x
EV/FCF	18.85x
EV/Sales	0.77x
FCF yield	19.28%
P/B ratio	0.52x
P/S ratio	0.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.46%
EBITDA Margin	5.74%
FCF margin	4.08%
Gross margin	36.22%
Gross Profit	CAD 79.4M
Gross Profit Growth	-7.56%
Gross Profit Growth Q	-17.02%
Gross Profit Growth3 Y	-3.27%
Gross Profit Growth5 Y	13.07%
Net Income	CAD -19.9M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-6.8%
Profit Margin	-9.06%
Profit Per Employee	CAD -22,932
ROA	-0.71
Roa5y	6.46
ROCE	-1.63
ROE	-20.32
Roe5y	-4.16
ROIC	-1.61
Roic5y	8.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-20.7%
Cagr3y	-39.13%
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth	13.41%
OCF Growth3 Y	1.72%
OCF Growth5 Y	17.88%
Revenue Growth	1.34x
Revenue Growth Q	6.94x
Revenue Growth Quarters	2x
Revenue Growth Years	13x
Revenue Growth3 Y	6.05x
Revenue Growth5 Y	25.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.78
Assets	CAD 277.7M
Cash	CAD 12.2M
Current Assets	CAD 81.1M
Current Liabilities	CAD 80.7M
Debt	CAD 117M
Debt EBITDA	CAD 7.55
Debt Equity	CAD 1.32
Debt FCF	CAD 13.08
Equity	CAD 88.8M
Interest Coverage	-0.31
Liabilities	CAD 189M
Long Term Assets	CAD 196.7M
Long Term Liabilities	CAD 108.2M
Net Cash	CAD -104.9M
Net Cash By Market Cap	CAD -226
Net Debt EBITDA	CAD 8.33
Net Debt Equity	CAD 1.18
Net Debt FCF	CAD 11.72
Tangible Book Value	CAD 14.6M
Tangible Book Value Per Share	CAD 0.04
WACC	8.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1
Inventory Turnover	2.91
Net Working Capital	CAD -2.8M
Quick ratio	0.3
Working Capital	CAD 305,760
Working Capital Turnover	CAD 118

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-20.69%
200-day SMA	0.15
3Y total return	-77.45%
50-day SMA	0.11
50-day SMA vs 200-day SMA	50under200
All Time High	1
All Time High Change	-88.5%
All Time High Date	2022-07-20
All Time Low	0.06
All Time Low Change	91.67%
All Time Low Date	2025-06-24
ATR	0.01
Beta	1.34
Ch YTD	-4.17
High	0.12
High52	0.48
High52 Date	2025-09-02
High52ch	-76.04%
Low	0.12
Low52	0.06
Low52 Date	2025-06-24
Low52ch	91.67%
Ma50ch	2.22%
Price vs 200-day SMA	-21.02%
RSI	52.69
RSI Monthly	39.77
RSI Weekly	45.79
Sharpe ratio	0.63x
Sortino ratio	1.13
Total Return	-2.9%
Tr YTD	-4.17
Tr1m	35.29%
Tr3m	-4.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -3.2M
Operating margin	-1.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	332,709,803%
Net Borrowing	-6,243,317.4
Shares Insiders	10.68%
Shares Institutions	2.26%
Shares Qo Q	0.68%
Shares Yo Y	2.9%
Short Ratio	0.06

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 6.4M
Average Volume	89,542.95x
Bv Per Share	0.18
CAPEX	CAD -1.6M
Ch1m	35.29
Ch1y	-20.69
Ch3m	-4.17
Ch3y	-77.45
Ch6m	-17.86
Change	0%
Change From Open	0
Close	0.12
Days Gap	0
Depreciation Amortization	15,734,745.5
Dollar Volume	23,920
Earnings Date	2026-05-13
EBIT	CAD -3.2M
EBITDA	CAD 12.6M
EPS	CAD -0.05
F Score	2
FCF	CAD 9M
FCF EV Yield	5.3x
Financing CF	-6,462,089
Fiscal Year End	December
Founded	2,011
Goodwill	32,811,934.1
Income Tax	CAD 4.9M
Investing CF	-1,892,146
Is Primary Listing	0
Last Earnings Date	2026-03-11
Last Report Date	2025-12-31
Ma150	0.15
Ma150ch	-23.94%
Ma20	0.11
Ma20ch	9.52%
Net CF	2,196,534
Next Earnings Date	2026-05-13
Open	0.12
P FCF Ratio	5.19
P OCF Ratio	4.4
Ppne	138,252,500.6
Price Date	2026-05-08
Price EBITDA	CAD 3.69
Ptbv Ratio	3.18
Relative Volume	3.14x
Revenue	219,140,625x
SBC By Revenue	1.16x
Share Based Comp	2,550,283
Tax By Revenue	2.25x
Tr6m	-17.86%
Volume	208,000
Z Score	0.05

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/MRMD pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/MRMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/MRMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.3%

Share of float held by funds and institutions

Insider ownership

+10.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CSE/MRMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.7

Neutral momentum band

Price vs 200-day MA

-21.0%

50/200-day relationship not available

Beta (5Y)

1.34

More volatile than the market

Sharpe ratio

0.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/MRMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/MRMD stock rating?

cse/MRMD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/MRMD analysis?

The full report lives at /stocks/cse/MRMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/MRMD?

The latest report frames cse/MRMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/MRMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.